<DOC>
	<DOCNO>NCT00237471</DOCNO>
	<brief_summary>To determine whether tight glycaemic control insulin improve myocardial function myocardial perfusion ( measure myocardial contrast echocardiography ) novel vascular risk factor patient acute myocardial infarction hyperglycaemia .</brief_summary>
	<brief_title>Impact Tight Glycaemic Control Acute Myocardial Infarction</brief_title>
	<detailed_description>We randomise patient acute myocardial infarction blood glucose level ( BGLs ) &gt; =10mmol/L within 24 hour pain onset , either tight glucose control ( aim BGLs 4.5 - 7mmol/L ) insulin infusion ( 24 hour ) follow subcutaneous insulin standard control ( BGL 6 - 12mmol/L ) without use insulin infusion . Serial myocardial contrast echocardiography measure change myocardial perfusion function baseline 3 month group . We also measure change inflammatory endothelial marker time see whether tight glucose control improve surrogate endpoint .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Age &gt; =18years Acute Myocardial Infarction Blood Glucose Level &gt; =10mmol/L Wall motion abnormality baseline echocardiogram Active infection/inflammation Cardiac shunt Cognitive Impairment Insulin allergy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Acute Myocardial Infarction</keyword>
	<keyword>Hyperglycaemia</keyword>
	<keyword>Insulin Infusion</keyword>
</DOC>